We are live on
!
Find out more
RCM
Radnor Capital Management Portfolio holdings
AUM
$712M
1-Year Est. Return
34.39%
This Fund
S&P 500
This Quarter
Est. Return
+2.11%
1 Year Est. Return
+34.39%
3 Year Est. Return
+86.61%
5 Year Est. Return
+116%
10 Year Est. Return
–
AUM
$292M
AUM Growth
–
Cap. Flow
+$288M
Cap. Flow
% of AUM
98.49%
Top 10 Holdings %
Top 10 Hldgs %
44.11%
Holding
182
New
182
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Merck
MRK
|
+$47.5M |
| 2 |
ExxonMobil
XOM
|
+$16.4M |
| 3 |
3M
MMM
|
+$13.7M |
| 4 |
IBM
IBM
|
+$12.1M |
| 5 |
GE Aerospace
GE
|
+$11.3M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 20.61% |
| 2 | Industrials | 17.85% |
| 3 | Energy | 11.81% |
| 4 | Technology | 11.14% |
| 5 | Financials | 9.06% |
Similar funds
PCS
AMPWP
DCM
TLP
DCM
IWP
LS
SSP
Radnor Capital Management's Q4 2016 Portfolio in Review
Q4 2016 is the first quarter with a 13F filing on record for Radnor Capital Management, which disclosed 182 positions worth $292M. Its ten largest holdings account for 44% of the portfolio.
Its largest position is Merck: 811,728 shares worth $45.6M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, followed by Industrials and Energy.
- Radnor Capital Management's largest Q4 2016 buy was Merck: 811,728 shares worth $45.6M.
- Radnor Capital Management's ten largest holdings make up 44% of its $292M portfolio in Q4 2016.
- Radnor Capital Management disclosed 182 positions in Q4 2016, its first 13F filing on record.
Based on Radnor Capital Management's 13F filing for Q4 2016, filed 3 Feb 2017.